Assessment of

Breast Cancer CAVIN3 DAPK1 Metastasis Methylation

Journal

Cell journal
ISSN: 2228-5806
Titre abrégé: Cell J
Pays: Iran
ID NLM: 101566618

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 03 11 2019
accepted: 26 01 2020
entrez: 29 8 2021
pubmed: 30 8 2021
medline: 30 8 2021
Statut: ppublish

Résumé

Metastasis might be latent or occur several years after primary tumor removal. Currently used methods for detection of distant metastasis have still some limitations. Blood tests may improve sensitivity and specificity of currently used screening procedures. The present study was designed to investigate promoter methylation status of In this case-control study, MethySYBR assay was performed to determine According to the results an increased promoter methylation level of the Promoter hypermethylation of c and

Identifiants

pubmed: 34455714
doi: 10.22074/cellj.2021.7251
pmc: PMC8405083
doi:

Types de publication

Journal Article

Langues

eng

Pagination

397-405

Informations de copyright

Copyright© by Royan Institute. All rights reserved.

Déclaration de conflit d'intérêts

There is no conflict of interest in this study.

Références

Endocr Relat Cancer. 2016 Mar;23(3):R157-71
pubmed: 26764421
Breast Cancer Res. 2019 May 17;21(1):62
pubmed: 31101124
Nat Med. 2011 Mar;17(3):330-9
pubmed: 21386836
Cancer Discov. 2014 Apr;4(4):405-14
pubmed: 24658082
Int J Cancer. 2008 Apr 1;122(7):1573-84
pubmed: 18059034
J Neurosci. 2014 May 7;34(19):6546-56
pubmed: 24806680
Nat Genet. 1994 Jul;7(3):440-7
pubmed: 7920666
Adv Cancer Res. 2016;132:1-44
pubmed: 27613128
Int J Mol Sci. 2018 Oct 04;19(10):
pubmed: 30287790
BMC Mol Biol. 2017 Dec 19;18(1):24
pubmed: 29258436
Asian Pac J Cancer Prev. 2018 Feb 26;19(2):443-448
pubmed: 29480000
Clin Exp Med. 2013 Feb;13(1):1-9
pubmed: 22212995
J Cell Biochem. 2012 Jan;113(1):322-8
pubmed: 21913217
Breast Cancer Res Treat. 2012 Jan;131(1):197-205
pubmed: 21837480
Apoptosis. 2014 Feb;19(2):285
pubmed: 24198143
Elife. 2013 Sep 24;2:e00905
pubmed: 24069528
Cancer Res. 2001 Nov 1;61(21):7943-9
pubmed: 11691816
BMC Cancer. 2015 May 19;15:417
pubmed: 25986046
Sci Rep. 2019 Jan 17;9(1):175
pubmed: 30655558
Front Mol Biosci. 2015 Apr 22;2:13
pubmed: 25988180
Br J Cancer. 2006 Dec 18;95(12):1701-7
pubmed: 17133271
Breast Cancer Res Treat. 2015 Feb;149(3):767-79
pubmed: 25636590
Tumour Biol. 2012 Apr;33(2):395-402
pubmed: 21922274
Cytometry A. 2017 Jun;91(6):555-565
pubmed: 28426134
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
J Intern Med. 2013 Aug;274(2):113-26
pubmed: 23844915
J Mol Diagn. 2009 Sep;11(5):400-14
pubmed: 19710398
Cancer Res. 2002 Jan 15;62(2):351-5
pubmed: 11809677
Oncol Rep. 2014 Feb;31(2):1021-9
pubmed: 24337450
Breast Cancer Res. 2015 Sep 14;17:125
pubmed: 26370119
J Cell Physiol. 2009 Mar;218(3):451-4
pubmed: 18988188
Clin Epigenetics. 2019 Mar 4;11(1):39
pubmed: 30832707
Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6189-93
pubmed: 15448006
Anticancer Res. 2015 Sep;35(9):4569-74
pubmed: 26254344
Nat Commun. 2018 Nov 29;9(1):5068
pubmed: 30498206
Tumori. 2010 Sep-Oct;96(5):726-33
pubmed: 21302620
Oncol Rep. 2012 May;27(5):1630-8
pubmed: 22159596

Auteurs

Esmat Ghalkhani (E)

Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Mohammad Taghi Akbari (MT)

Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Email: mtakbari@modares.ac.ir.

Pantea Izadi (P)

Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Habibollah Mahmoodzadeh (H)

Department of Surgery, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran.

Fatemeh Kamali (F)

Iran National Tumor Bank, Cancer Institute of Iran, Tehran, University of Medical Sciences, Tehran, Iran.

Classifications MeSH